Inotrem Is A Clinical Stage Biotechnology Company Based In Parisfrancefounded In 2013The Company Specializes In Immunotherapyfocusing On Controlling Inflammatory Responses Through Its Proprietary Technology That Targets The Trem 1 Pathwaythis Approach Aims To Restore Immune Balance In Both Acute And Chronic Inflammatory Diseasespositioning Inotrem As A Leader In Precision Medicine For Conditions With Limited Treatment Options Inotrem S Key Productnangibotidelr12 Is A First In Class Trem 1 Inhibitor Currently In Phase 3 Development For Septic Shock And Is Also Being Investigated For Covid 19 Related Inflammationthe Company Is Also Developing A Monoclonal Antibody Program Targeting Chronic Inflammatory Diseasesfibrosisand Immuno Oncologyinotrem Collaborates With Academic And Clinical Institutions To Advance Its Research And Has Secured Significant Funding From Various Investors To Support Its Mission
No conferences found for this company.
| Company Name | Inotrem Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
